Zweiman B, Israel H L
Ann N Y Acad Sci. 1976;278:700-10. doi: 10.1111/j.1749-6632.1976.tb47084.x.
Comparative studies of in vivo and in vitro reactivities to Kveim preparations have been carried out in 45 sarcoid and 30 normal subjects. Lymphocytes of 14 of 45 sarcoids and 4 of 30 normals proliferated significantly in response to at least 1 of the 4 Kveim suspensions used for in vitro studies. The prevalence of positive responses were significantly greater in sarcoids than normals in cultures containing Kveim-CSL and Kveim-Edinburgh. The Kveim-reactive cells were less stimulated by PHA, but no other significant alterations were found, including the presence or absence of in vivo Kveim reactivity in the cell donors. Reactivity to more than 1 Kveim preparation occurred in 9 of 14 cases. Kveim-induced leukocyte migration inhibition occurred more commonly in sarcoids than normals, but differences were not as striking. There was not a precise correlation between proliferative and migration-inhibition responses to Kveim.
对45例结节病患者和30名正常受试者进行了体内和体外对克维姆制剂反应性的比较研究。45例结节病患者中的14例以及30名正常受试者中的4例的淋巴细胞,对用于体外研究的4种克维姆悬液中的至少1种有显著增殖反应。在含有克维姆 - CSL和克维姆 - 爱丁堡的培养物中,结节病患者的阳性反应发生率显著高于正常受试者。克维姆反应性细胞对PHA的刺激较小,但未发现其他显著变化,包括细胞供体体内克维姆反应性的有无。14例中有9例对不止1种克维姆制剂有反应。克维姆诱导的白细胞迁移抑制在结节病患者中比正常受试者更常见,但差异不那么显著。对克维姆的增殖反应和迁移抑制反应之间没有精确的相关性。